Trial intelligence / Profile preview

THC Titration of High-Potency Cannabis Concentrates

NCT07105449Recruiting

Sponsor
Center for Addiction and Mental Health
Start
Oct 2025
Primary completion
Mar 2028
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dronabinol (3 arms), sponsored by Center for Addiction and Mental Health. Primary endpoints: Pharmacokinetics (blood levels of THC and metabolites) at 4 hours and Inhalation Topography at 10 months. Started Oct 2025; status: recruiting.

02

Drugs

dronabinol

Beyond the preview

Go deeper on NCT07105449.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07105449.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call